Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

In its upcoming report, Alnylam Pharmaceuticals (ALNY) is predicted by Wall Street analysts to post quarterly loss of $0.21 per share, reflecting an increase of 80.9$570.11 million, representing a year-over-year increase of 29.7%.The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed t ...